We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Sarah Whelan, PhD

Sarah Whelan, PhD

Science Writer


Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


Got a question for Sarah Whelan, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 230
An illustration of sperm cells.
News

Target for Reversible, Non-Hormonal Male Birth Control Identified in Mice

Researchers from the Salk Institute have uncovered a protein complex that regulates gene expression during sperm production and discovered an oral non-hormonal drug that reversibly stops this process in mice, without obvious side effects.
A person pouring a bottle of pills into their hand.
News

Model Identifies Potential Drug Combinations To Avoid

A new model has been designed to identify drugs that should not be prescribed together. It has already identified common drugs – an antibiotic and a blood thinner – that may interfere with each other.
Computer-generated image of methicillin-resistant Staphylococcus aureus.
News

New Synthetic Molecule Effective Against Superbugs

A synthetic antibiotic molecule can kill drug-resistant strains of superbugs such as Staphylococcus aureus and Pseudomonas aeruginosa. This could help to tackle the issue of drug-resistant infections, which has been growing worldwide.
A collection of many different pills.
Industry Insight

Using AI To Get Medicines to Patients Faster

To find out more about AI in pharma, Technology Networks spoke with Roger Palframan, head of US Research and digital for Early Solutions at UCB.
A blue pill.
News

Could Erectile Dysfunction Drugs Be Linked to Reduced Alzheimer’s Risk?

A new observational study concludes that men prescribed drugs for erectile dysfunction were 18% less likely to develop Alzheimer’s disease years down the line, according to University College London (UCL) researchers.
A person lighting a cigarette.
News

Quitting Smoking Delivers Health Benefits at Any Age

Quitting smoking can increase life expectancy after just a few years, suggests a new study from the University of Toronto.
Computer-generated image of cells.
News

Risk of Secondary Cancer Investigated After CAR T-Cell Therapy

A study by University of Pennsylvania researchers shows that secondary cancer development is rare after CAR T-cell therapy and that many patients have achieved long-lasting remission.
A blue and red pill split open showing a drug molecular structure.
News

Pulling “Ineffective” Decongestant From Shelves Could Disrupt Supply Chain

Despite an FDA panel suggesting oral phenylephrine is ineffective, it remains popular among consumers and pulling it from the shelves could create supply chain disruptions, according to a new study.
A person wearing gloves drawing up a vaccine into a syringe.
News

Single-Dose Dengue Vaccine Provides Nearly 80% Protection

Results from a Phase 3 clinical trial show that the vaccine is safe and effective for those aged 2–59 regardless of whether they have previously been infected with dengue.
A three-dimensional structure of a PNMA2 complex.
News

Virus-Like Brain Protein May Explain Cancer-Induced Memory Loss

Some tumors can produce virus-like proteins that kick-start out-of-control immune reactions, according to a new study from University of Utah researchers. These rare cancer complications can lead to memory loss and cognitive deficits caused by the immune system attacking the brain.
Advertisement